Highline Wealth Partners »

Werewolf Therapeutics shares owned by Highline Wealth Partners

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Highline Wealth Partners from 13F filings

Historical chart of Highline Wealth Partners investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Highline Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Highline Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.9k 5.0k 1.97
2025-06-30 $11k 10k 1.09

More positions owned by Highline Wealth Partners

Nvidia Corporation Stock (NVDA)
JPMorgan Ultra-Short Income ETF Etf (JPST)
Janus Henderson AAA CLO ETF Etf (JAAA)
Vanguard S&P 500 ETF Etf (VOO)
Microsoft Corp Stock (MSFT)
Apple Inc Com/Inv Stock (AAPL)
iShares Core MSCI EAFE ETF Etf (IEFA)
Invesco Nasdaq 100 Etf Etf (QQQM)
Schwab Fundamental U.s. Large Company Etf Etf (FNDX)
Meta Platforms Inc Cl A Stock (META)
Vanguard Russell 1000 Value ETF Etf (VONV)
Amazon Stock (AMZN)
Tesla Stock (TSLA)
Costco Whsl Corp/N Stock (COST)
iShares 5-10 Year Investment Grade Corporate Bond ETF Etf (IGIB)

View all positions for Highline Wealth Partners

Top funds holding Werewolf Therapeutics

RA Capital Management
MPM Asset Management
MPM Oncology Impact Management
Vanguard Group
Sphera Funds Management
DC Funds
Renaissance Technologies
Partner Fund Management
Geode Capital Management
Millennium Management
Jane Street
Alyeska Investment Group
Citadel Advisors
State Street Corporation
Bridgeway Capital Management

View all funds holding Werewolf Therapeutics